SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001824293-23-000024
Filing Date
2023-03-23
Accepted
2023-03-23 16:04:59
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A schedule14a_stockholderrem.htm DEFA14A 18579
2 GRAPHIC logo_filings.jpg GRAPHIC 47751
  Complete submission text file 0001824293-23-000024.txt   85426
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 607-8255
Vallon Pharmaceuticals, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40034 | Film No.: 23756165
SIC: 2834 Pharmaceutical Preparations